Stroke detection start-up Viz.ai said its Viz CTP technology has been cleared by the US Food and Drug Administration (FDA). Viz.ai develops deep learning and AI-powered technology that can analyze brain scans and automatically transfer the data to a doctor to ensure the most immediate treatment for strokes. The artificial intelligence (AI) technology analyses hospital CT scans for stroke indicators and automatically sends data to a doctor, with radiological images sent direct to their smartphone. It is the company's second FDA approval, after its computer-aided triage and notification platform for large vessel occlusion strokes was cleared in February. In India, Viz.ai's AI system can detect more than 100 types of stroke, including those that are not detected on traditional scans.
Stroke detection start-up Viz.ai said its Viz CTP technology has been cleared by the US Food and Drug Administration (FDA). The artificial intelligence (AI) technology analyses hospital CT scans for stroke indicators and automatically sends data to a doctor, with radiological images sent direct to their smartphone. It is the company's second FDA approval, after its computer-aided triage and notification platform for large vessel occlusion strokes was cleared in February. In India, Viz.ai's AI system can detect more than 100 types of stroke, including those that are not detected on traditional scans.